Dobson's Sports Clinic

are no longer fringe science

Sports medicine is entering a difficult scientific era: peptide use is growing faster than the evidence base.

From recovery clinics to online “biohacking” communities, athletes and recreational exercisers are increasingly using injectable peptides for fat loss, recovery, muscle preservation, tendon healing, sleep, and performance enhancement. Yet much of this use is occurring outside regulated clinical systems, with compounds sourced from loosely regulated online markets and “research chemical” suppliers.

The core problem is not simply that peptides exist — it is that real-world adoption has dramatically outpaced high-quality human research.

Current scientific evidence suggests:
• Some peptides show biologically plausible therapeutic potential.
• A few have legitimate medical indications.
• Many remain poorly studied in humans.
• Long-term safety data are largely absent.
• Product quality and dosing consistency are major concerns.
• Sports performance claims are often exaggerated beyond available evidence.

From a sports medicine perspective, peptides can broadly be grouped into:

1. Evidence-Backed Medical Peptides

These include compounds with approved clinical roles:
• GLP-1 receptor agonists for obesity/metabolic disease
• Certain growth hormone secretagogues in endocrine disorders
• Peptide-based therapies in diabetes and osteoporosis

These agents are increasingly relevant to athlete health, body composition, metabolic rehabilitation, and injury management — but must be used within established medical frameworks.

2. Experimental Recovery & Performance Peptides

Examples commonly discussed in sport include:
• BPC-157
• TB-500 / Thymosin beta-4
• CJC-1295
• Ipamorelin
• MOTS-c
• AOD-9604

The issue is that most claims surrounding these compounds rely on:
• animal studies,
• mechanistic theory,
• anecdotal reports,
• uncontrolled case experiences,
rather than robust randomized human trials.

For many of these peptides:
• pharmacokinetics remain uncertain,
• optimal dosing is unknown,
• interaction profiles are poorly characterized,
• and long-term endocrine, cardiovascular, hepatic, or oncologic effects remain unclear.

The Research Bottleneck

A major challenge highlighted by researchers is regulatory and financial barriers to conducting peptide trials properly.

Conducting human studies often requires:
• GMP-grade manufacturing,
• regulatory toxicology packages,
• ethics approval,
• extensive safety monitoring,
• and substantial funding.

This creates a paradox:
• public use accelerates rapidly,
• underground markets expand,
• but formal science struggles to keep pace.

As a result, athletes frequently become uncontrolled real-world experiments without surveillance systems capable of detecting harm early.

Key Sports Medicine Concerns

1. Product Purity & Contamination

Independent analyses of unregulated peptides have demonstrated:
• inaccurate labeling,
• contamination,
• incorrect peptide sequences,
• endotoxin risk,
• variable concentration.

Athletes may unknowingly inject substances very different from what labels claim.

2. Anti-Doping Risk

Many peptides fall under prohibited categories within the World Anti-Doping Agency framework:
• growth hormone secretagogues,
• growth factors,
• IGF-related compounds,
• certain metabolic modulators.

Even contamination or undeclared ingredients can trigger anti-doping violations.

3. Lack of Long-Term Safety Data

Potential concerns include:
• endocrine dysregulation,
• insulin resistance,
• edema,
• cardiovascular strain,
• fibrosis,
• altered tumor signaling pathways.

Current evidence is insufficient to confidently define long-term risk profiles for many compounds.

What the Scientific Community Increasingly Agrees On

A balanced modern sports medicine position is emerging:
• Blanket dismissal of all peptides is scientifically unhelpful.
• Uncritical promotion of peptides as “miracle recovery tools” is equally problematic.
• Controlled human research is urgently needed.
• Regulation must evolve faster than current academic systems.
• Athlete safety requires evidence, not hype.

The future likely lies in:
• better translational peptide science,
• stricter manufacturing standards,
• registry-based monitoring,
• precision medicine approaches,
• and carefully designed clinical trials in athletic populations.

Until then, the peptide landscape remains a collision between: rapid commercialization,
social-media-driven demand anti-doping regulation,
and incomplete science

Tech Doping or Future of Sports Performance?

The emergence of carbon-plated “super shoes” like the Adidas Adizero Adios Pro Evo 1 has fundamentally altered the biomechanics and physiology of distance running. The question is no longer if they improve performance—but how.

1. Running Economy: The Core Mechanism

Running economy (oxygen cost at a given speed) is the strongest predictor of endurance performance.

Super shoes improve economy by ~3–5%, which at elite level translates into minutes over a marathon.

Mechanisms:
• High energy return foams → Reduced energy dissipation
• Carbon plate stiffness → Optimized force transfer
• Rocker geometry → Reduced ankle joint work

👉 Net effect: Lower metabolic cost for the same velocity

⸻

2. Biomechanical Efficiency

These shoes fundamentally alter lower-limb mechanics:
• Reduced ankle dorsiflexion moment
• Shift of work from ankle → knee/hip
• Increased stride length with maintained cadence
• Improved elastic energy storage (Achilles–tendon complex)

This creates a more “spring-mass optimized” system, reducing muscular fatigue over long distances.

⸻

3. Muscle-Tendon Interaction

Super shoes enhance elastic recoil efficiency:
• Foam + plate act like an external tendon
• Reduces reliance on active muscle work
• Delays onset of neuromuscular fatigue

👉 Particularly critical beyond 30 km in marathon physiology

⸻

4. Exercise Physiology Impact

From a physiological standpoint:
• ↓ VO₂ at submaximal speeds
• ↓ lactate accumulation at race pace
• ↑ time to exhaustion
• ↓ perceived exertion

This effectively raises the sustainable speed ceiling without changing VO₂ max.

⸻

5. Performance Translation

A 3–4% improvement in running economy can:
• Convert a 2:04 marathoner → sub-2:00 potential under ideal conditions
• Redefine pacing strategies
• Compress elite competition margins

⸻

6. The Controversy: “Tech Doping”?

Unlike pharmacological doping:
• These gains are mechanical, not biological
• Benefits are accessible but not equal (cost, availability, adaptation)

However, the magnitude of improvement raises a valid question:

At what point does equipment redefine human performance limits?

⸻

7. Practical Sports Medicine Perspective

For clinicians and performance teams:
• Expect load redistribution injuries (calf ↓, hip/knee ↑)
• Monitor Achilles and soleus adaptation patterns
• Progressive integration is essential—not plug-and-play

⸻

Bottom Line

Super shoes do not just make athletes faster—
they re-engineer the energetics of human running.

The real debate is not whether they work.
It’s whether we are still measuring the athlete—or the system.

https://www.linkedin.com/posts/cyber-kings-india_the-indian-achievers-edition-261-activity-7426882384878559232-bj8z?utm_medium=ios_app&rcm=ACoAAASq3PQB0qS4buXaIRp1I7tSI5-F4dqTw9o&utm_source=social_share_send&utm_campaign=copy_link

https://youtu.be/eTu5ZPqJR_o?feature=shared

Speech of Dr Dobson Dominic on Tech Doping and Performance Sports Science- The New Frontiers We at Chandrashekhar Agashe College of Physical Education Pune are happy to announce that we are organizing an international conference on linking the past &...

More than 55 million people live with dementia.

That number is expected to exceed 150 million by 2050.

And the #1 modifiable risk factor?

It’s not diet.

It’s not sleep.

It’s physical inactivity.

That’s why training your muscles helps protect your mind.

Even modest amounts of regular physical activity can lower dementia risk - and every movement counts.

-----------------------

📷 Figure from:

Heisz, Jennifer J.; Waddington, Emma E.. The Principles of Exercise Prescription for Brain Health in Aging.

The Power of Becoming a Swiss Army Knife in Sports Science

In the pursuit of mastery, the specialist often becomes predictable.

But the one who stacks skills—quietly, methodically—becomes indispensable.

This is the paradox of modern Sports Science:

To thrive, you must go beyond your job title.

You must become a generalist with precision.

In my path, I’ve learned to stop thinking in isolation

Strength & Conditioning is a blade.

Data Analysis is a blade.

Nutrition,Biomechanics. Psychology Technology. Communication.
Each a blade in the same handle.

And like any tool—if unused, it rusts.

The future of performance doesn’t belong to those who cling to one expertise.

It belongs to those who adapt, who learn fast, and who apply even faster.

Be the one they call when no one else knows what to do.

Be the Swiss Army knife in a world full of single tools.

If you’re in Sports Science—or any field that evolves by the minute—ask yourself:

What skill do I need to sharpen next?